Nisa Investment Advisors, LLC Acadia Pharmaceuticals Inc Transaction History

Nisa Investment Advisors, LLC

$24.1 Billion
Q4 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,721 shares of ACAD stock, worth $34,488. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,721

Previous 1,585 8.58%

Holding current value

$34,488

Previous $24,000 29.17%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 17, 2025	BUY	$14.29 - $18.76 $1,943 - $2,551	136 Added 8.58%	1,721 $31,000
Q3 2024 Oct 24, 2024	BUY	$15.14 - $19.14 $3,890 - $4,918	257 Added 19.35%	1,585 $24,000
Q2 2024 Jul 19, 2024	SELL	$14.62 - $18.42 $9,678 - $12,194	-662 Reduced 33.27%	1,328 $21,000
Q1 2024 May 01, 2024	BUY	$17.79 - $30.86 $1,245 - $2,160	70 Added 3.65%	1,990 $36,000
Q4 2023 Jan 25, 2024	SELL	$20.78 - $31.77 $24,936 - $38,124	-1,200 Reduced 38.46%	1,920 $60,000
Q1 2023 May 02, 2023	BUY	$16.32 - $20.92 $31,987 - $41,003	1,960 Added 168.97%	3,120 $59,000
Q4 2022 Feb 02, 2023	BUY	$14.2 - $18.63 $340 - $447	24 Added 2.11%	1,160 $18,000
Q3 2022 Nov 07, 2022	SELL	$14.11 - $18.27 $4,670 - $6,047	-331 Reduced 22.56%	1,136 $18,000
Q2 2022 Aug 03, 2022	SELL	$13.01 - $27.22 $62,448 - $130,656	-4,800 Reduced 76.59%	1,467 $21,000
Q1 2022 Apr 29, 2022	BUY	$20.94 - $27.5 $131,230 - $172,342	6,267 New	6,267 $152,000
Q4 2021 Feb 03, 2022	SELL	$16.79 - $27.09 $229,149 - $369,724	-13,648 Closed	0 $0
Q3 2021 Oct 18, 2021	SELL	$15.78 - $24.77 $15,038 - $23,605	-953 Reduced 6.53%	13,648 $227,000
Q2 2021 Aug 06, 2021	BUY	$19.4 - $27.42 $68,094 - $96,244	3,510 Added 31.65%	14,601 $356,000
Q4 2020 Jan 25, 2021	BUY	$41.04 - $56.79 $283,955 - $392,930	6,919 Added 165.84%	11,091 $593,000
Q3 2020 Oct 20, 2020	SELL	$36.42 - $57.0 $76,336 - $119,472	-2,096 Reduced 33.44%	4,172 $172,000
Q2 2020 Jul 27, 2020	BUY	$39.26 - $52.73 $3,376 - $4,534	86 Added 1.39%	6,268 $304,000
Q1 2020 Apr 17, 2020	BUY	$31.65 - $46.87 $3,481 - $5,155	110 Added 1.81%	6,182 $261,000
Q4 2019 Jan 17, 2020	BUY	$36.21 - $51.4 $123,186 - $174,862	3,402 Added 127.42%	6,072 $260,000
Q3 2019 Oct 17, 2019	BUY	$22.22 - $44.01 $3,777 - $7,481	170 Added 6.8%	2,670 $96,000
Q3 2018 Oct 16, 2018	SELL	$13.03 - $21.81 $19,545 - $32,714	-1,500 Reduced 37.5%	2,500 $52,000
Q2 2018 Jul 19, 2018	BUY	$15.07 - $22.34 $39,182 - $58,084	2,600 Added 185.71%	4,000 $61,000
Q4 2017 Jan 12, 2018	SELL	$26.84 - $39.14 $13,688 - $19,961	-510 Reduced 26.7%	1,400 $42,000
Q3 2017 Oct 13, 2017	BUY	$29.49 - $38.37 $56,325 - $73,286	1,910	1,910 $72,000

Others Institutions Holding ACAD

# of Institutions

314

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.24B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Acadia Pharmaceuticals Inc Transaction History